Antipyretic therapy

被引:20
作者
Botting, R [1 ]
机构
[1] St Bartholomews & Royal London Sch Med & Dent, William Harvey Res Inst, London EC1M 6BQ, England
来源
FRONTIERS IN BIOSCIENCE-LANDMARK | 2004年 / 9卷
关键词
selective COX-2 inhibitors; pharmacology; prostaglandins; cyclooxygenases; Non-Steroidal Anti-Inflammatory Drugs; Antipyretic Analgesics; review;
D O I
10.2741/1303
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Antipyresis can be achieved by physical methods such as cooling the body with tepid water or by pharmacological means such as the administration of antipyretic drugs. The nonsteroid anti-inflammatory drugs (NSAIDs) including aspirin, have been used to combat fever since the end of the 19(th) century and the analgesic antipyretics, from about the same time. Most of the antipyretic analgesics such as acetanilide and phenacetin are no longer used in therapy because of their toxicity. However, the metabolite of these two drugs, acetaminophen, became a highly popular antipyretic in the 1950s and is now the antipyretic of first choice in most developed countries. The disadvantages of administering NSAIDs is their gastrotoxicity manifested as irritation, ulcers and bleeding of the stomach mucosa. Acetaminophen also is toxic to the liver in doses only slightly above the therapeutic dose. Thus, selective COX-2 inhibitors, which do not damage the stomach and are free fom hepatotoxicity, may be the drugs of choice for reducing fever in the future.
引用
收藏
页码:956 / 966
页数:11
相关论文
共 103 条
[61]   EFFECT OF VARIOUS DRUGS ON CARRAGEENIN-INDUCED OEDEMA IN RAT HIND PAW [J].
NIEMEGEERS, CJE ;
VERBRUGGEN, FJ ;
JANSSEN, PAJ .
JOURNAL OF PHARMACY AND PHARMACOLOGY, 1964, 16 (12) :810-&
[62]  
Patrignani P, 1997, J PHYSIOL PHARMACOL, V48, P623
[63]  
PATRONO C, 1998, SELECTIVE COX 2 INHI, P73
[64]   Acetaminophen has greater antipyretic efficacy than aspirin in endotoxemia: A randomized, double-blind, placebo-controlled trial [J].
Pernerstorfer, T ;
Schmid, R ;
Bieglmayer, C ;
Eichler, HG ;
Kapiotis, S ;
Jilma, B .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 1999, 66 (01) :51-57
[65]  
Polidori G, 1993, Drugs, V46 Suppl 1, P231
[66]  
PRAIST P, 2001, THERAPEUTIC ROLES SE, P60
[67]  
PRESCOTT LF, 2001, PARACETAMOL ACETAMIN, P253
[68]  
Riendeau D, 2001, J PHARMACOL EXP THER, V296, P558
[69]  
SAXENA PN, 1979, INDIAN J MED RES, V70, P495
[70]   Signaling the brain in systemic inflammation: The role of perivascular cells [J].
Schiltz, JC ;
Sawchenko, PE .
FRONTIERS IN BIOSCIENCE-LANDMARK, 2003, 8 :S1321-S1329